Zura Bio to present at Leerink Partners Global Healthcare Conference on March 11, 2025

Zura Bio Ltd

Members of senior leadership will participate in a fireside chat on Tuesday, March 11, 2025 at 1:40 p.m. ET.
Live webcast and replay will be available on the News & Events page of Zura Bio's website for at least 30 days.
Zura Bio is a clinical-stage immunology company developing dual-pathway antibodies for autoimmune diseases.

item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-25-016345
form_type: 8-K
ticker: ZURA
cik: 0001855644
company_name: Zura Bio Ltd
filed_at: 2025-02-24T23:59:59+00:00
discovered_at: 2026-05-14T18:03:05.336256+00:00
generated_at: 2026-05-26T06:25:42.288120+00:00
sec_items: ["7.01", "9.01"]
event_type: other
sentiment: neutral
materiality_score: 0.1
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-25-016345
json_url: https://secwatch.observer/filing/0001104659-25-016345.json
markdown_url: https://secwatch.observer/filing/0001104659-25-016345.md
text_url: https://secwatch.observer/filing/0001104659-25-016345.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1855644/000110465925016345/0001104659-25-016345-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1855644/000110465925016345/tm257217d1_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001104659-25-016345

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.